SC 13D/A | 2022-11-01 | Growth Equity Opportunities Fund IV, LLC | AVEO PHARMACEUTICALS, INC. | - | - | EDGAR |
SC 13G/A | 2022-10-20 | HIRSCHMAN ORIN | AVEO PHARMACEUTICALS, INC. | 920,358 | 2.8% | EDGAR |
SC 13G/A | 2022-02-11 | HIRSCHMAN ORIN | AVEO PHARMACEUTICALS, INC. | 2,655,735 | 7.7% | EDGAR |
SC 13G | 2021-09-15 | HIRSCHMAN ORIN | AVEO PHARMACEUTICALS, INC. | 1,986,176 | 5.8% | EDGAR |
SC 13G/A | 2021-04-12 | BlackRock Inc. | AVEO PHARMACEUTICALS, INC. | 1,605,160 | 4.8% | EDGAR |
SC 13G/A | 2021-02-16 | Cormorant Asset Management, LP | AVEO PHARMACEUTICALS, INC. | 0 | - | EDGAR |
SC 13G/A | 2021-02-12 | Flynn James E | AVEO PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
SC 13G | 2021-02-02 | BlackRock Inc. | AVEO PHARMACEUTICALS, INC. | 1,568,355 | 5.4% | EDGAR |
SC 13G | 2020-06-29 | Cormorant Asset Management, LP | AVEO PHARMACEUTICALS, INC. | 1,278,045 | - | EDGAR |
SC 13G | 2020-06-29 | Cormorant Asset Management, LP | AVEO PHARMACEUTICALS, INC. | 1,278,045 | - | EDGAR |
SC 13D/A | 2020-06-24 | Growth Equity Opportunities Fund IV, LLC | AVEO PHARMACEUTICALS, INC. | 5,424,009 | 20.8% | EDGAR |
SC 13G | 2020-06-19 | Flynn James E | AVEO PHARMACEUTICALS, INC. | 1,574,000 | 6.1% | EDGAR |
SC 13G/A | 2019-05-10 | BlackRock Inc. | AVEO PHARMACEUTICALS INC | 7,110,202 | 4.4% | EDGAR |
SC 13D/A | 2019-04-17 | Growth Equity Opportunities Fund IV, LLC | AVEO PHARMACEUTICALS INC | 39,954,386 | 22.8% | EDGAR |
SC 13G/A | 2019-02-14 | Polar Capital LLP | AVEO PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G | 2019-02-08 | BlackRock Inc. | AVEO PHARMACEUTICALS INC | 7,357,716 | 5.9% | EDGAR |
SC 13D/A | 2018-11-28 | Growth Equity Opportunities IV, LLC | AVEO PHARMACEUTICALS INC | 30,430,732 | 22.4% | EDGAR |
SC 13D/A | 2018-07-10 | Growth Equity Opportunities IV, LLC | AVEO PHARMACEUTICALS INC | 28,146,416 | 21.8% | EDGAR |
SC 13G | 2018-02-14 | Polar Capital LLP | AVEO PHARMACEUTICALS INC | 8,077,429 | 6.8% | EDGAR |
SC 13D/A | 2017-04-04 | Growth Equity Opportunities IV, LLC | AVEO PHARMACEUTICALS INC | 26,725,388 | 23.0% | EDGAR |